Volkers P - Search Results

1

Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.

Nübling CM, Chudy M, Volkers P, Löwer J. Nübling CM, et al. Among authors: volkers p. Transfusion. 2006 Nov;46(11):1886-91. doi: 10.1111/j.1537-2995.2006.00994.x. Transfusion. 2006. PMID: 17076842

2

Evaluation of Risk Minimisation Measures for Blood Components - Based on Reporting Rates of Transfusion-Transmitted Reactions (1997-2013).

Funk MB, Heiden M, Volkers P, Lohmann A, Keller-Stanislawski B. Funk MB, et al. Among authors: volkers p. Transfus Med Hemother. 2015 Jul;42(4):240-6. doi: 10.1159/000381996. Epub 2015 May 5. Transfus Med Hemother. 2015. PMID: 26557816 Free PMC article.

3

Plasma quality after whole-blood filtration depends on storage temperature and filter type.

Heiden M, Salge U, Henschler R, Pfeiffer HU, Volkers P, Hesse J, Sireis W, Seitz R. Heiden M, et al. Among authors: volkers p. Transfus Med. 2004 Aug;14(4):297-304. doi: 10.1111/j.0958-7578.2004.00517.x. Transfus Med. 2004. PMID: 15285726

4

Evaluation of Quality Parameters for Cord Blood Donations.

Salge-Bartels U, Huber HM, Kleiner K, Volkers P, Seitz R, Heiden M. Salge-Bartels U, et al. Among authors: volkers p. Transfus Med Hemother. 2009;36(5):317-324. doi: 10.1159/000232384. Epub 2009 Aug 21. Transfus Med Hemother. 2009. PMID: 21076550 Free PMC article.

5

Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.

Cussler K, Rosskopf-Streicher U, Volkers P, Milne C. Cussler K, et al. Among authors: volkers p. Pharmeuropa Spec Issue Biol. 2001 Aug;2001(1):75-88. Pharmeuropa Spec Issue Biol. 2001. PMID: 11705102

6

Control of Clostridium perfringens vaccines using an indirect competitive ELISA for the epsilon toxin component - examination of the assay by a collaborative study.

Rosskopf-Streicher U, Volkers P, Werner E. Rosskopf-Streicher U, et al. Among authors: volkers p. Pharmeuropa Bio. 2004 Jan;2003(2):91-6. Pharmeuropa Bio. 2004. PMID: 14960265

7

Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.

Rosskopf-Streicher U, Volkers P, Noeske K, Werner E. Rosskopf-Streicher U, et al. Among authors: volkers p. ALTEX. 2004;21 Suppl 3:65-9. ALTEX. 2004. PMID: 15057410

8

Impact of vCJD on blood supply.

Seitz R, von Auer F, Blümel J, Burger R, Buschmann A, Dietz K, Heiden M, Hitzler WE, Klamm H, Kreil T, Kretzschmar H, Nübling M, Offergeld R, Pauli G, Schottstedt V, Volkers P, Zerr I. Seitz R, et al. Among authors: volkers p. Biologicals. 2007 Apr;35(2):79-97. doi: 10.1016/j.biologicals.2007.01.002. Epub 2007 Feb 21. Biologicals. 2007. PMID: 17320412 Review.

9

Validation of flow cytometry to quantify the potency of anti-D immunoglobulin preparations.

Schäffner G, Kayser T, Tönjes A, Volkers P. Schäffner G, et al. Among authors: volkers p. Vox Sang. 2003 Feb;84(2):129-36. doi: 10.1046/j.1423-0410.2003.00267.x. Vox Sang. 2003. PMID: 12609019

10

Validation of in vitro potency assays for tetanus immunoglobulin.

Gross S, Volkers P, Eckert-Ziem M, Kuschel S, Schäffner G. Gross S, et al. Among authors: volkers p. Pharmeuropa Bio. 2006 Nov;2006(1):1-6. Pharmeuropa Bio. 2006. PMID: 17270126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters